Genenta Science S.p.A. American Depositary Shares (GNTA) is a publicly traded Healthcare sector company. As of May 21, 2026, GNTA trades at $0.65 with a market cap of $14.90M and a P/E ratio of 0.00. GNTA moved +0.00% today. Year to date, GNTA is -57.07%; over the trailing twelve months it is -85.45%. Its 52-week range spans $0.55 to $10.00. Rallies surfaces GNTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in GNTA news today?
Genenta to Invest €6M for 51% Stake in Sòphia High Tech: Genenta will invest €6.0 million in two tranches to acquire up to a 51% stake in Sòphia High Tech, securing an initial 19.9% ownership. Sòphia HT reported €6.29 million revenue and €0.96 million EBITDA in 2024, forecasts €8 million sales in 2025 and aims to double revenue by 2027.
WARRELL RAYMOND P JR sold 8.78M (~$13.17K) on Sep 22, 2011.
WARRELL RAYMOND P JR sold 8.00M (~$15.20K) on Sep 21, 2011.
WARRELL RAYMOND P JR sold 300.47K (~$9.62K) on Mar 25, 2011.
GNTA Analyst Consensus
GNTA analyst coverage data. Average price target: $0.00.
Common questions about GNTA
What changed in GNTA news today?
Genenta to Invest €6M for 51% Stake in Sòphia High Tech: Genenta will invest €6.0 million in two tranches to acquire up to a 51% stake in Sòphia High Tech, securing an initial 19.9% ownership. Sòphia HT reported €6.29 million revenue and €0.96 million EBITDA in 2024, forecasts €8 million sales in 2025 and aims to double revenue by 2027.
Does Rallies summarize GNTA news?
Yes. Rallies summarizes GNTA news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is GNTA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GNTA. It does not provide personalized investment advice.
